Figure S1 from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

Authors :: James H. Doroshow
Richard M. Simon
Barbara A. Conley
Robert J. Kinders
P. Mickey Williams
Seth M. Steinberg
Paul M. McGregor
William D. Walsh
Michele G. Mehaffey
Chih-Jian Lih
Deborah E. Allen
Jiuping Ji
Alice P. Chen
Ahrim Youn
Peter M. Szabo
Robert J. Morgan
Miguel A. Villalona-Calero
Michael J. Naughton
David R. Gandara
Daniel M. Sullivan
Gini F. Fleming
Amit M. Oza
Shivaani Kummar
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Figure S1. Kaplan-Meier analysis of the progression free survival (PFS) of patients on each treatment arm stratified by BRCA status showed no significant differences.

Full Text Access

Tools